(Q38078421)

28 August 2017

1 reference

title

Liposomes for brain delivery (English)

1 reference

28 August 2017

Francesco Lai

1

1 reference

28 August 2017

Anna Maria Fadda

series ordinal

2

1 reference

28 August 2017

Chiara Sinico

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

4 February 2013

1 reference

Expert Opinion on Drug Delivery

28 August 2017

1 reference

28 August 2017

10

1 reference

28 August 2017

7

1 reference

28 August 2017

1003-1022

1 reference

Pathophysiology of the blood-brain barrier: animal models and methods

28 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

CNS drug delivery systems: novel approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Differential receptor-mediated drug targeting to the diseased brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Astrocyte-endothelial interactions at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Molecular Trojan horses for blood-brain barrier drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Convection-enhanced delivery of macromolecules in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Local drug delivery to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Nanotechnological advances for the delivery of CNS therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Nanotechnology advances in brain tumors: the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Engineering liposomes for drug delivery: progress and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Recent advances with liposomes as pharmaceutical carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Active targeting of brain tumors using nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

New strategies to deliver anticancer drugs to brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Blood-brain barrier drug targeting: the future of brain drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Dynamics of CNS barriers: evolution, differentiation, and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Endothelial vesicles in the blood-brain barrier: are they related to permeability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

The large apparent work capability of the blood-brain barrier: A study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

The blood-brain barrier/neurovascular unit in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Blood-brain barrier: structural components and function under physiologic and pathologic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Tight junctions of the blood-brain barrier: development, composition and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

The blood-brain barrier in health and chronic neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Transporting therapeutics across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

The blood-brain barrier: bottleneck in brain drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Blood-brain barrier delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Modern methods for delivery of drugs across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Expression profiling of the solute carrier gene family in the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Structural biology and function of solute transporters: implications for identifying and designing substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Structure and function of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Facilitated transfer of glucose from blood into brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Transcytotic pathway for blood-borne protein through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Endocytosis and molecular sorting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Human blood-brain barrier transferrin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Transferrin and transferrin receptor function in brain barrier systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Mechanism and developmental changes in iron transport across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Transferrin receptors in human tissues: their distribution and possible clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Human cell-surface glycoprotein with unusual properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Transferrin/transferrin receptor-mediated drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Transferrin receptor on endothelium of brain capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Blood-brain barrier penetration and in vivo activity of an NGF conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

CNS delivery via adsorptive transcytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Neutrophils and the blood-brain barrier dysfunction after trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

P-Glycoprotein, a gatekeeper in the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Nanoparticulate systems for drug delivery and targeting to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Uptake and intracellular release kinetics of liposome formulations in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Comparison of four different peptides to enhance accumulation of liposomes into the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Brain drug delivery of small molecules using immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

By-passing of P-glycoprotein using immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Inflammatory responses and their impact on beta-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Noninvasive gene targeting to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Delivery of peptides and proteins through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Blood-brain barrier transport of therapeutics via receptor-mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Global non-viral gene transfer to the primate brain following intravenous administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Marked enhancement in gene expression by targeting the human insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Receptor-mediated delivery of an antisense gene to human brain cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Antisense gene therapy of brain cancer with an artificial virus gene delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Localization of GTP cyclohydrolase in monoaminergic but not nitric oxide-producing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

In vivo demonstration of subcellular localization of anti-transferrin receptor monoclonal antibody-colloidal gold conjugate in brain capillary endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Diffusion of Small Non-Electrolytes across Liposome Membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.766714

Blood-brain barrier-specific properties of a human adult brain endothelial cell line

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1096/FJ.04-3458FJE

Identifiers

DOI

10.1517/17425247.2013.766714

1 reference

28 August 2017

1 reference